Hostname: page-component-7b7567c8c-tnkh4 Total loading time: 0 Render date: 2026-11-17T01:14:56.547Z Has data issue: false hasContentIssue false

Squamous cell carcinoma of the oral tongue: a 25-year, single institution experience

Published online by Cambridge University Press:  30 June 2008

M S Mosleh-Shirazi
Affiliation:
Department of Radiotherapy, Namazi Hospital, Shiraz University of Medical Sciences, IranSchool of Medicine, University of Birmingham, UK
M Mohammadianpanah*
Affiliation:
Department of Radiotherapy, Namazi Hospital, Shiraz University of Medical Sciences, Iran
M A Mosleh-Shirazi
Affiliation:
Department of Radiotherapy, Namazi Hospital, Shiraz University of Medical Sciences, Iran
*
Address for correspondence: Dr Mohammad Mohammadianpanah, Department of Radiation Oncology, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz 71936-13311, Iran. Fax: +98 711 6260135 E-mail: mohpanah@sums.ac.ir
Rights & Permissions [Opens in a new window]

Abstract

Aim:

To report the characteristics, prognostic factors and treatment outcomes of 102 patients with squamous cell carcinoma of the oral tongue treated and followed up at a single institution over a 25-year period.

Patients and methods:

This retrospective study was carried out by auditing the medical records of 102 patients diagnosed with squamous cell carcinoma of the oral tongue and treated at our institution between 1982 and 2007. Patient follow up ranged from nine to 310 months (median 35 months). Fifty per cent of the patients were treated with surgery followed by a combination of chemotherapy and radiotherapy (43.1 per cent received concurrent chemoradiation and 6.9 per cent received sequential chemotherapy and radiotherapy), whereas 29.4 per cent received surgery followed by adjuvant radiotherapy alone. The remaining patients (20.6 per cent) did not undergo surgery and were treated with definitive radiotherapy with or without chemotherapy.

Results:

There were 48 men and 54 women. The age at presentation was 19–85 years (median 57 years). The peak incidence was observed between 60 and 70 years. Resection margins were clear in 75 per cent of patients and involved in 25 per cent. Stage I disease was found in 11.8 per cent of patients, stage II in 34.3 per cent, stage III in 22.5 per cent and stage IV in 31.4 per cent. The five-year disease-free survival and overall survival were 65.7 and 72.5 per cent, respectively. Thirty-five patients suffered recurrence after treatment, 74.0 per cent of them at the site of initial cervical nodal involvement. Univariate analysis for overall survival revealed the following as prognostic factors: treatment schedule (surgical vs non-surgical; p < 0.001); age (<60 years vs ≥60 years; p = 0.038); extent of cervical lymph node involvement (p = 0.015); primary tumour stage (p < 0.001); node stage (p = 0.034); and disease stage (p = 0.013). However, on multivariate analysis, only non-surgical treatment (p = 0.001) and advanced disease stage (p = 0.05) were found to have a negative influence on survival.

Conclusions:

Our limited data suggest that, in Iran, squamous cell carcinoma of the oral tongue tends to present at a locally advanced stage, with a high frequency of locoregional failure and a poor outcome. Combined modality therapy should be considered for the majority of patients with squamous cell carcinoma of the tongue.

Information

Type
Main Articles
Copyright
Copyright © JLO (1984) Limited 2008
Figure 0

Table IClinical Staging of 102 Oral Tongue SCC Patients

Figure 1

Table IIPatients' Distribution of Treatment by Disease Stage

Figure 2

Fig. 1Five-year disease-free survival (DFS) for 102 patients with oral squamous cell carcinoma.

Figure 3

Fig. 2Five-year overall survival (OS) for 102 patients with oral squamous cell carcinoma.

Figure 4

Table IIIUnivariate Analysis of Prognostic Factors for Clinical Outcome